Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 79
Number of items: 79
  • Open Access
    Nogueira, F., van Ham, S. M., & ten Brinke, A. (2025). Extracorporeal Photopheresis in Solid Organ Transplantation: Modulating B-cell Responses to Improve Graft Survival. Transplantation Direct, 11(9), Article e1833. https://doi.org/10.1097/TXD.0000000000001833
  • Fernandez Blanco, L., Kuijper, L., Kummer, L. Y. L., ten Brinke, A., & van Ham, S. M. (2025). Heterogenous activated B cell compartments arising early and transiently after antigen exposure [Data set]. Zenodo. https://doi.org/10.5281/zenodo.17702363
  • Open Access
    Makuch, M., van Beek, J., Wijbrandts, C. A., Aalbers, M., Stas, P., Meijer, A. B., Brinke, A. T., Rispens, T., Tak, P. P., Wolbink, G., Schuurman, J., Parren, P. W. H. I., & van Ham, M. S. (2025). The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients. Frontiers in Immunology, 16, Article 1549781. https://doi.org/10.3389/fimmu.2025.1549781
  • Open Access
    Keijzer, S., Oskam, N., Ooijevaar-de Heer, P., Steenhuis, M., Keijser, J. B. D., Wieske, L., van Dam, K. P. J., Stalman, E. W., Kummer, L. Y. L., Boekel, L., Kuijpers, T. W., ten Brinke, A., van Ham, S. M., Eftimov, F., Tas, S. W., Wolbink, G. J., Rispens, T., & T2B! immunity against SARS-CoV-2 study group (2024). Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection. Frontiers in Immunology, 15, Article 1314507. https://doi.org/10.3389/fimmu.2024.1314507
  • Open Access
    Kuijper, L. H., Kreher, C., Elias, G., Claireaux, M., Kerster, G., Bos, A. V., Duurland, M. C., Konijn, V. A. L., Paul, A. G. A., de Jong, N., de Jongh, R., Steenhuis, M., Garcia-Vallejo, J. J., van Gils, M. J., Kuijpers, T. W., Eftimov, F., Rispens, T., van der Schoot, C. E., van Ham, S. M., & ten Brinke, A. (2024). Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection. Frontiers in Immunology, 15, Article 1505719. https://doi.org/10.3389/fimmu.2024.1505719
  • Open Access
    van Dam, K. P. J., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van der Kooi, A. J., Raaphorst, J., van de Beek, D., Verschuuren, J. J. G. M., Ruiter, A. M., Brusse, E., van Doorn, P. A., Baars, A. E., van der Pol, W. L., Goedee, H. S., ten Brinke, A., van Ham, S. M., Rispens, T., Kuijpers, T. W., Eftimov, F., & the T2B! Immunity Against SARS-CoV-2 Study Group (2024). Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases. European Journal of Neurology, 31(12), Article e16409. https://doi.org/10.1111/ene.16409
  • Open Access
    Valk, A. M., Tas, S. W., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination. Allergy, 79(7), 1952–1961. https://doi.org/10.1111/all.16089
  • Open Access
    Kummer, L. Y. L., Fernández Blanco, L., Kreher, C., Bos, A., Kuijper, L. H., Verstegen, N. J. M., van de Sandt, C. E., Konijn, V. A. L., Duurland, M. C., Menage, C., Jorritsma, T., Steenhuis, M., Hagen, R. R., van den Dijssel, J., de Jongh, R., Ashhurst, T., van Gils, M. J., Garcia-Vallejo, J. J., Claireaux, M., ... T2B! immunity against SARS-CoV-2 study group (2024). Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID. RMD OPEN, 10(4), Article e004664. https://doi.org/10.1136/rmdopen-2024-004664
  • Open Access
    Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., Dijssel, J. V. D., Ashhurst, T., Kummer, L. Y. L., Palomares Cabeza, V., Steenhuis, M., Duurland, M. C., Jongh, R. D., Schoot, C. E. V. D., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2024). T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 855–864. https://doi.org/10.1136/jnnp-2023-332224
  • Open Access
    van den Dijssel, J., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses. Journal of autoimmunity, 144, Article 103175. https://doi.org/10.1016/j.jaut.2024.103175
Page 2 of 8